Research & clinical trials

Member research

Our members participate in nephrology research. Please visit their profile pages or our research showcase to learn more about our members and their work.

Clinical trials

We work with the following clinical trials:

Peer reviewed

• HSFO: HARMONY study
  Hypertension Analysis of Stress Reduction using Mindfulness Meditation & Yoga 
• CIHR: STARRT-AKI
  Standard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury.
• CANNeCTIN  Atrial Fibrillation and Hypertension study
  Canadian Kidney Knowledge Translation and Generation Network (CANN-NET)
  
• CIHR/AstraZeneca: HOPE3
  The HOPE-3 trial evaluates the effects of statin therapy to lower cholesterol, low dose angiotensin-receptor blocker plus diuretic therapy to lower blood pressure (blood pressure) and combined cholesterol and BP lowering with these drugs in a wide range of subjects at risk, targeted for primary prevention, who are already receiving lifestyle advice.  
• CIHR: CURCUMIN study
  Curcumin to Prevent Perioperative Complications From Elective Abdominal Aortic Aneurysm Repair: A Randomized Controlled Trial 
• ARTEMIS registry for ABPM
  International Ambulatory Blood Pressure Registry: Telemonitoring of Hypertension and Cardiovascular Risk Project 
• NIH: NEPTUNE
  Nephrotic Syndrome Study Network, Longitudinal control
• NIH: CORAL
  Cardiovascular Outcomes in Renal Atherosclerotic Lesions Randomized and Multi-Center Two-Group Clinical Trial to Assess The Best Treatment for Patients with High Blood Pressure and Renal Artery Stenosis: Stenting with Anti-Hypertensive Medical Therapy, Compared to Medical Therapy Alone

Industry sponsored

• Janssen: CANPREDICT
  CANadian study of Prediction of Risk and Evolution to Dialysis, Death and Interim Cardiovascular events over 
• Astra/Zeneca/Brigham and Women's:
  TIMI53 SAVOR (Diabetic nephropathy)Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IVTrial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients with Type 2 Diabetes 
• Janssen: PRO STARRT
  A Prospective, Observational, Randomized Comparative Study of Case Managed Versus Non-case Managed Initiation of Hemodialysis
• Novartis: APOLLO study
  Aliskiren Prevention of Later Life Outcomes Trial: A randomized controlled trial of Aliskiren in the Prevention of major cardiovascular events in elderly people